Dysregulation of microRNA-34a expression in colorectal cancer inhibits the phosphorylation of FAK via VEGF

Digestive Diseases and Sciences

Volumn 59, Issue 5, 2014, Pages 958-967

  Zhang, Danhua ^a   Zhou, Jianping ^a   Dong, Ming ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; FAK; MiR 34a; pY397FAK; VEGF

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; FOCAL ADHESION KINASE; MICRORNA 34A; VASCULOTROPIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER CELL LINE; CANCER TISSUE; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BINDING SITES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PHOSPHORYLATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899953168     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2983-4     Document Type: Article

References (32)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Pellegrino L, Jacob J, Roca-Alonso L, Krell J, Castellano L, et al. Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers. Expert Rev Anticancer Ther. 2013;13:21-27.
3. Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM. Delivering the promise of miRNA cancer therapeutics. Drug Discov Today. 2013;18:282-289.
4. Akbari Moqadam F, Pieters R, den Boer ML. The hunting of targets: challenge in miRNA research. Leukemia. 2013;27:16-23.
5. Pagliuca A, Valvo C, Fabrizi E, di Martino S, Biffoni M, et al. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene. 2013;32:4806-4813.
6. Takahashi M, Sung B, Shen Y, Hur K, Link A, et al. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis. 2012;33:2441-2449.
7. de Krijger I, Mekenkamp LJ, Punt CJ, Nagtegaal ID. MicroRNAs in colorectal cancer metastasis. J Pathol. 2011;224:438-447.
8. Stratmann J, Wang CJ, Gnosa S, Wallin A, Hinselwood D, et al. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer. 2011;11:345.
9. Bensen JT, Tse CK, Nyante SJ, Barnholtz-Sloan JS, Cole SR, et al. Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control. 2013;24:1099-1109.
10. Bandi N, Vassella E. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol Cancer. 2011;10:55.
11. Xu X, Fan Z, Kang L, Han J, Jiang C, et al. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest. 2013;123:630-645.
12. Yue X, Wang P, Xu J, Zhu Y, Sun G, et al. MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. Oncol Rep. 2012;27:1200-1206.
13. Volkomorov V, Grigoryeva E, Krasnov G, Litviakov N, Tsyganov M, et al. Search for potential gastric cancer markers using miRNA databases and gene expression analysis. Exp Oncol. 2013;35:2-7.
14. Ji X, Wang Z, Geamanu A, Goja A, Sarkar FH, et al. Deltatocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells. Int J Cancer. 2012;131: 2668-2677.
15. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun. 2008;377: 114-119.
16. Duan W, Xu Y, Dong Y, Cao L, Tong J, et al. Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway. J Radiat Res. 2013;54:611-619.
17. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007;26: 745-752. (Pubitemid 46856245)
18. Zhao H, Ma B, Wang Y, Han T, Zheng L, et al. miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44. Oncol Rep . 2013;29:1027-1036.
19. Mackiewicz M, Huppi K, Pitt JJ, Dorsey TH, Ambs S, et al. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA. Breast Cancer Res Treat. 2011;130:663-679.
20. Gallardo E, Navarro A, Vinolas N, Marrades RM, Diaz T, et al. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis. 2009;30:1903-1909.
21. Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One. 2011;6:e24099.
22. Roy S, Levi E, Majumdar AP, Sarkar FH. Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J Hematol Oncol. 2012;5:58.
23. Cho SG, Yi Z, Pang X, Yi T, Wang Y, et al. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Res. 2009;69:7062-7070.
24. Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, et al. VEGF-induced vascular permeability is mediated by FAK. Dev Cell. 2012;22:146-157.
25. Schlaepfer DD, Hunter T. Signal transduction from the extra-cellular matrix-a role for the focal adhesion protein-tyrosine kinase FAK. Cell Struct Funct. 1996;21:445-450. (Pubitemid 27068333)
26. Pang X, Zhang L, Lai L, Chen J, Wu Y, et al. 1′-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway. Carcinogenesis. 2011;32:904-912.
27. He K, Cui B, Li G, et al. The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients withmetastatic colorectal cancer (mCRC). Onco Targets Ther. 2012;5:59-65.
28. Sun F, Fu H, Liu Q, Tie Y, Zhu J, et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 2008;582:1564-1568.
29. Hashimi ST, Fulcher JA, Chang MH, Gov L, Wang S, et al. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood. 2009;114:404-414.
30. Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, et al. TGF-beta-miR-34a- CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell . 2012;22:291-303.
31. Mudduluru G, Ceppi P, Kumarswamy R, Scagliotti GV, Papotti M, et al. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene. 2011;30: 2888-2899.
32. Gilmore AP, Romer LH. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell. 1996;7:1209-1224. (Pubitemid 26260738)